how is iga nephropathy treated
TRANSCRIPT
![Page 1: How is IgA Nephropathy Treated](https://reader031.vdocuments.us/reader031/viewer/2022021223/577cd8ea1a28ab9e78a24c29/html5/thumbnails/1.jpg)
7/29/2019 How is IgA Nephropathy Treated
http://slidepdf.com/reader/full/how-is-iga-nephropathy-treated 1/2
How is IgA nephropathy treated?
Kidney disease usually cannot be cured. When the kidneys are damaged, they cannot be
repaired. Treatment focuses on slowing the disease and preventing complications.
One complication is high blood pressure, also called hypertension. Hypertension damages thekidneys. Two types of blood pressure medicines called angiotensin-converting enzyme (ACE)
inhibitors and angiotensin receptor blockers (ARBs) protect kidney function. These
medicines not only lower blood pressure but also decrease the loss of protein into the urine.
Because of this effect, they are often used in IgA nephropathy to protect the kidneys. They
are good medicines but have certain side effects. Pregnant women should not take ACE
inhibitors or ARBs because they can damage the unborn baby.
People with IgA nephropathy may develop high cholesterol. By watching their diet and
taking medicine, they can help lower their cholesterol level. Lowering cholesterol may help
slow kidney damage.
Medicines such as prednisone may help treat IgA nephropathy. Prednisone belongs to a class
of medicines called corticosteroids, which can have harmful side effects. In research studies,
fish oil supplements containing omega 3 fatty acids also slowed kidney damage in some
patients. Vitamin E may help lower protein in the urine but not blood. One of the newer
immunosuppressive agents called mycophenolate mofetil (MMF) is also being tested in
treating IgA nephropathy.
Hope through Research
In recent years, researchers have learned much about kidney disease. The National Instituteof Diabetes and Digestive and Kidney Diseases (NIDDK) sponsors several programs aimed
at understanding kidney failure and finding treatments to stop its progression.
The NIDDK’s Division of Kidney, Urologic, and Hematologic Diseases (DKUHD) supports
basic research into normal kidney function and the diseases that impair normal function at the
cellular and molecular levels, including diabetes, high blood pressure, glomerulonephritis,
and other diseases marked by protein in the urine.
Researchers sponsored by the DKUHD are studying families in which IgA nephropathy is
prevalent in order to understand genetic factors that may influence the disease. Other
researchers are working to understand how the polyunsaturated fatty acids found in fish oilsmay work to reduce inflammation in diseases like IgA nephropathy and rheumatoid arthritis.
Clinical trials are under way to test the effectiveness of MMF in reducing protein in the urine
and slowing the progression of kidney disease in people with IgA nephropathy
![Page 2: How is IgA Nephropathy Treated](https://reader031.vdocuments.us/reader031/viewer/2022021223/577cd8ea1a28ab9e78a24c29/html5/thumbnails/2.jpg)
7/29/2019 How is IgA Nephropathy Treated
http://slidepdf.com/reader/full/how-is-iga-nephropathy-treated 2/2
Lifestyle and home remedies
To help keep your kidneys healthier:
Take steps to reduce your blood pressure. Keeping your blood pressure levels near normal may help slow kidney damage from IgA nephropathy. Your doctor may
recommend healthy changes in your diet — including l imiting your salt intake —
losing excess weight, being physicall y active, using alcohol i n moderation and
remember ing to take your blood pressure medications as ways to keep your blood
pressure under control .
Monitor your blood pressure levels at home. Note each reading and bring this
record with you to your doctor's appointments.
Eat less protein. Reducing the amount of protein you eat and taking steps to decrease
your cholesterol levels may help slow the progression of IgA nephropathy and protect
your kidneys.
Low antigen diet — A low antigen diet consists of avoiding gluten, dairy products, eggs, and most
meats [141]. The rationale for this regimen is that dietary macromolecules may be responsible for
activating the mucosal IgA system. When given to 21 consecutive patients with IgA nephropathy,
protein excretion was markedly reduced or fell into the normal range in 11 of the 12 patients whose
baseline rate was more than 1 g/day. In addition, repeat renal biopsy showed significant reductions
in mesangial IgA and complement deposition and mesangial cellularity. IgA is an autoimmune
disease. This is a disease in which a person’s own immune system damages their own
body. Scientists know that the IgA immune complex causes the inappropriate immune response.
But it is not yet known what causes the defective IgA in the first place. It likely has both genetic and
environmental components. A person is born with a predisposition for the disease, and then some
sort of “trigger”, for example an infection or food exposure, turns the disease “on”